Clinical Trial Detail

NCT ID NCT04268550
Title Targeted Treatment for RET Fusion-Positive Advanced Non-Small Cell Lung Cancer (A LUNG-MAP Treatment Trial)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Southwest Oncology Group
Indications

lung non-small cell carcinoma

Therapies

Selpercatinib

Age Groups: adult child senior

Additional content available in CKB BOOST